Journal Watch · Diabetes Care · 2026
A U-Shaped Association Between Blood mtDNA Copy Number and Risk of Type 2 Diabetes.
Additionally, mtDNA-CN declined with age in both cohorts, with an accelerated decrease beyond ∼65 years in KARE and ∼50 years in UKB.<h4>Conclusions</h4>Blood mtDNA-CN showed a U-shaped association with incident type 2 diabetes in younger individuals.
TL;DR
Additionally, mtDNA-CN declined with age in both cohorts, with an accelerated decrease beyond ∼65 years in KARE and ∼50 years in UKB.<h4>Conclusions</h4>Blood mtDNA-CN showed a U-shaped association with incident type 2 diabetes in younger individuals.
Key findings
- Age-stratified analyses revealed that this U-shaped association was particularly evident in younger participants (aged <65 years in KARE and <50 years in UKB), indicating elevated diabetes risk at both low and high mtDNA-CN levels.
- Additionally, mtDNA-CN declined with age in both cohorts, with an accelerated decrease beyond ∼65 years in KARE and ∼50 years in UKB.<h4>Conclusions</h4>Blood mtDNA-CN showed a U-shaped association with incident type 2 diabetes in younger individuals.
Numbers at a glance (from the abstract)
Every figure above is taken verbatim from the abstract below. Check the full text for denominators, confidence intervals and subgroup detail.
What they did
Associations between blood mtDNA-CN and incident type 2 diabetes were evaluated using Cox proportional hazards and restricted cubic spline models stratified by age.<h4>Results</h4>A U-shaped association was observed in the KARE cohort (P < 0.001), in which the hazard ratios (95% CIs) across increasing mtDNA-CN quartiles were 1.00 (reference), 0.94 (0.88-1.00), 0.85 (0.79-0.91), and 0.93 (0.87-1.00). In contrast, the UKB cohort exhibited a predominantly inverse linear trend.
Full abstract (original)
Background: <h4>Objective</h4>mtDNA copy number (CN) reflects mitochondrial function, but prior studies have reported inconsistent associations with type 2 diabetes risk, ranging from inverse to positive or null findings. We hypothesized that mtDNA-CN is nonlinearly associated with incident type 2 diabetes.<h4>Research design and methods</h4>We included 34,835 adults without diabetes from the Kunshan Aging Research With E-Health (KARE) cohort and 289,338 from the UK Biobank (UKB).
What they did: Associations between blood mtDNA-CN and incident type 2 diabetes were evaluated using Cox proportional hazards and restricted cubic spline models stratified by age.<h4>Results</h4>A U-shaped association was observed in the KARE cohort (P < 0.001), in which the hazard ratios (95% CIs) across increasing mtDNA-CN quartiles were 1.00 (reference), 0.94 (0.88-1.00), 0.85 (0.79-0.91), and 0.93 (0.87-1.00). In contrast, the UKB cohort exhibited a predominantly inverse linear trend.
Results & conclusions: Age-stratified analyses revealed that this U-shaped association was particularly evident in younger participants (aged <65 years in KARE and <50 years in UKB), indicating elevated diabetes risk at both low and high mtDNA-CN levels. Additionally, mtDNA-CN declined with age in both cohorts, with an accelerated decrease beyond ∼65 years in KARE and ∼50 years in UKB.<h4>Conclusions</h4>Blood mtDNA-CN showed a U-shaped association with incident type 2 diabetes in younger individuals.
Abstract © the authors / Diabetes Care (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.2337/dc25-2198 · PubMed 41837567.
Why it matters for pharma & biotech
- Relevant to Pharmacology & Drug Discovery teams tracking Diabetes Care for new targets, mechanisms and biomarkers.
- As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
Frequently asked questions
What did this Diabetes Care study find?
Additionally, mtDNA-CN declined with age in both cohorts, with an accelerated decrease beyond ∼65 years in KARE and ∼50 years in UKB.<h4>Conclusions</h4>Blood mtDNA-CN showed a U-shaped association with incident type 2 diabetes in younger individuals.
What type of study is this?
It is a cohort / observational clinical study, published in Diabetes Care in 2026. Associations between blood mtDNA-CN and incident type 2 diabetes were evaluated using Cox proportional hazards and restricted cubic spline models stratified by age.<h4>Results</h4>A U-shaped association was observed in the KARE cohort (P < 0.001), in which the hazard ratios (95% CIs) across increasing mtDNA-CN quartiles were 1.00 (reference), 0.94 (0.88-1.00), 0.85 (0.79-0.91), and 0.93 (0.87-1.00).
Where can I read the original paper?
The original is at the publisher via DOI 10.2337/dc25-2198. PubMed ID: 41837567. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/a-u-shaped-association-between-blood-mtdna-copy-number-and-risk-of-type-252198/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides